Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Nutex Health operates micro-hospitals and healthcare service centers primarily in Texas and surrounding states, focusing on underserved suburban and rural markets. The company combines emergency departments with inpatient beds (typically 8-10 beds per facility) to provide cost-effective acute care alternatives to traditional hospitals. With 93.8% revenue growth and strong operating margins (27.2%), the company is rapidly scaling its asset-light model through management agreements and joint ventures with health systems.
Nutex generates revenue through patient care services at company-owned and managed micro-hospitals, billing commercial insurance, Medicare, and Medicaid for emergency and inpatient services. The micro-hospital model achieves superior unit economics versus traditional hospitals by operating smaller facilities (15,000-25,000 sq ft) with lower fixed costs, targeting markets with 25,000-75,000 population where full-service hospitals are economically unviable. Pricing power derives from being the only emergency care provider within 15-20 mile radius in many locations. The company also earns management fees by operating facilities for health system partners, providing operational expertise without capital investment. Gross margins of 40.9% reflect efficient staffing models and favorable payer mix in suburban markets with higher commercial insurance penetration.
New facility openings and pipeline announcements - each micro-hospital represents $8-12M annual revenue potential at maturity
Same-facility patient volume growth and revenue per visit trends - indicates market penetration and payer mix improvement
Management agreement signings with health systems - high-margin, capital-light growth that validates the model
Regulatory developments affecting freestanding emergency departments and micro-hospital licensing in Texas and expansion states
Reimbursement rate changes from CMS (Medicare) and commercial payers affecting emergency department and observation stay payments
Regulatory risk from state medical boards and CMS regarding freestanding emergency department licensing, surprise billing regulations, and site-neutral payment policies that could reduce reimbursement rates for micro-hospitals versus traditional hospital emergency departments
Reimbursement pressure from government and commercial payers seeking to reduce emergency department utilization through value-based care models, telehealth alternatives, and steering patients to lower-cost urgent care settings
Labor cost inflation for emergency physicians and nurses in tight healthcare labor markets, with wage pressures potentially compressing facility-level margins faster than revenue growth
Competition from traditional hospital systems expanding into suburban markets with their own freestanding emergency departments, leveraging stronger brand recognition and integrated care networks
Proliferation of urgent care chains (CityMD, GoHealth) and retail health clinics (CVS MinuteClinic, Walgreens) capturing lower-acuity visits that would otherwise come to micro-hospital emergency departments
Telehealth platforms and hospital-at-home programs reducing demand for facility-based emergency care for moderate-acuity conditions
Debt/Equity of 1.13 creates refinancing risk if credit markets tighten or operating performance disappoints, particularly given the company's small market cap ($600M) and limited access to capital markets
Zero reported operating cash flow and free cash flow (TTM) despite 10.9% net margin suggests working capital consumption or accounting timing issues that could strain liquidity during rapid expansion
Lease obligations for facility real estate create fixed cost burden that becomes problematic if patient volumes decline or new facilities underperform maturation timelines
moderate - Emergency care demand is relatively inelastic as medical emergencies occur regardless of economic conditions. However, discretionary urgent care visits and elective observation stays show modest correlation to employment levels and consumer confidence. Commercial insurance coverage (higher reimbursement) tracks employment rates, while economic downturns shift payer mix toward Medicaid and uninsured (lower reimbursement). The company's suburban market focus provides some insulation as these areas typically have more stable employment than urban cores.
Rising interest rates create moderate headwinds through two channels: (1) higher financing costs for facility build-outs and working capital, with Debt/Equity of 1.13 indicating meaningful leverage, and (2) valuation multiple compression as growth healthcare stocks typically trade on forward EV/EBITDA multiples that contract when risk-free rates rise. However, the asset-light management agreement model reduces capital intensity and rate sensitivity compared to hospital REITs or facility-heavy operators. Current 2.2x EV/EBITDA suggests market is pricing in significant growth, making the stock vulnerable to rate-driven multiple compression.
Moderate exposure to consumer credit conditions. Approximately 15-20% of emergency department visits result in patient responsibility (deductibles, co-pays, uninsured), creating accounts receivable risk during economic stress. High deductible health plans have increased patient payment obligations, making collections sensitive to household financial health. The company's Current Ratio of 3.20 suggests strong liquidity to absorb collection timing issues. Credit market conditions also affect ability to finance facility expansion and refinance the existing debt load.
growth - The 93.8% revenue growth, 214% net income growth, and early-stage facility rollout story attracts growth investors seeking exposure to healthcare services disruption. The 53.6% one-year return and low 0.6x Price/Sales multiple appeal to momentum and GARP (growth at reasonable price) investors. Small market cap and limited liquidity make this primarily a small-cap growth vehicle rather than institutional core holding. The micro-hospital concept and asset-light scaling potential attract thematic healthcare investors focused on care delivery innovation.
high - Small-cap healthcare services stocks with $600M market cap exhibit elevated volatility from limited float, sparse analyst coverage, and binary outcomes around facility openings and regulatory developments. The stock's recent performance (53.6% one-year gain with -2.5% three-month pullback) demonstrates momentum-driven swings. Quarterly earnings likely drive 10-20% single-day moves given the growth stage and high expectations embedded in valuation. Sector rotation out of growth stocks during rate hiking cycles creates additional volatility.
